Comedy vs Cancer Returns to Lincoln Center, Raising $1.2 Million for Cancer Research at Memorial Sloan Kettering Cancer Center
The event featured Sarah Silverman, Hasan Minhaj, Colin Quinn, and many others
A Media Snippet accompanying this announcement is available by clicking on the image or link below:
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Comedy vs Cancer, a night of humor and hope to outwit blood cancers, raised $1.2 million for research at Memorial Sloan Kettering Cancer Center (MSK). There were a thousand people in the audience in New York City on Thursday, April 20, 2023, at Jazz at Lincoln Center’s Frederick P. Rose Hall.
The all-star event featured comedians Mike Birbiglia, Rachel Feinstein, Zarna Garg, Hasan Minhaj, Colin Quinn, Chris Redd, and Sarah Silverman. “It truly is an honor to be part of this special event and perform with my friends and fellow comedians while raising money for blood cancer research at Memorial Sloan Kettering Cancer Center,” said Minhaj. Attendees included Katie Couric, Jon Hamm, Steve Martin, and Martin Short.
Comedy vs Cancer benefited from generous sponsors Kreindler & Kreindler LLP, Esquire Bank, and Netflix. Support from the dedicated Host Committee, a group of volunteers focused on advancing lifesaving blood cancer research, was also integral to the show’s success.
Founded by Niccole and Jeremy Kroll, Jennifer Rogers and Robert Carlock, and Nick Kroll and Lily Kwong, the event funds leading-edge blood cancer research at MSK, the hospital where Niccole and Jennifer were both treated years ago.
MSK is a pioneer in chimeric antigen receptor (CAR) T cell therapy, an approach that uses a person’s own immune cells to fight blood cancers. The support of Comedy vs Cancer has accelerated progress in developing new and more effective versions of CAR T cell therapy, including laying the groundwork for a first-in-human clinical trial to treat acute myeloid leukemia that is expected to launch this year.
*MORE INFORMATION*
*About Memorial Sloan Kettering Cancer Center*
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years. www.mskcc.org.
*CONTACT: *
Maggie Hopf
hopfm@mskcc.org
646-988-4355